SBIR/STTR Research Award

Novel Biomatrix System for Human Tissue Growth & Angiogenesis in Microgavity

Award identifier b821879d5b63fa06906083fc1e1b21391fa3be4e8fd72c561f806cb401146c32Awarding agency National Aeronautics and Space Administration

Award amount

$70,000

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Aeronautics and Space Administration
Branch
Not reported
Recipient company
Diversified Scientific Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

One of NASA¿s missions is to develop noninvasive models for monitoring the potentially deleterious effects of microgravity on human cell/tissue functions. Previous work has shown that gravitational changes can modify a variety of host cell-matrix interactions. Angiogenesis, an essential process for tissue growth and regeneration, is a coordinated process of activated endothelial cell proliferation and differentiation controlled by specific matrix and growth factor signals. However, little is known about the human angiogenesis process in microgravity, primarily due to the lack of defined functional models. We have created a new human biomatrix (Amgel) culture system which supports endothelial cell growth and function. This unique biomatrix simulates human cell morphogenesis only in the presence of specific modulators (FGF, VEGF). We now propose to employ this natural matrix to further develop an all-human angiogenesis model adaptable for microgravity studies. Endothelial cell cultivation models with controllable bioactivity utilizing Amgel-layered disk and microbead configurations will be evaluated in rotary culture systems. New 3-D bioassays, generated with GF-enriched matrix, would allow examination of both early mitogenic and late angiogenic events. This R&D proposal should positively impact the fields of wound healing, tissue engineering and vascular disease.

Technology keywords

Not reported

Agency intelligence

National Aeronautics and Space Administration

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.